CC

CMG-SDIC Capital Management

Asia, Beijing, China, Beijing

Description

CMG-SDIC Capital Management is an investment company.

Investor Profile

CMG-SDIC Capital Management has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Manufacturing, Biopharma, Biotechnology.

Stage Focus

  • Series B (40%)
  • Series A (40%)
  • Series C (20%)

Country Focus

  • China (100%)

Industry Focus

  • Manufacturing
  • Biopharma
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical
  • Health Care
  • Robotics
  • Battery
  • Energy
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CMG-SDIC Capital Management frequently co-invest with?

WC
Asia, Beijing, China, Beijing
Co-Investments: 1
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
Cambridge Capital
North America, Florida, United States, West Palm Beach
Co-Investments: 1
CBC Group
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Casdin Capital
North America, New York, United States, New York
Co-Investments: 1
BlackRock
North America, New York, United States, New York
Co-Investments: 1
AstraZeneca Pharmaceutical
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 1
YF Capital
Asia, Shanghai, China, Jingan
Co-Investments: 1

Which angels does CMG-SDIC Capital Management often collaborate with?

Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by CMG-SDIC Capital Management?

Kelun Biotech

Chengdu, Sichuan, China

Kelun Biotech is a biopharmaceutical company.It focuses on the research and development, production and sales of innovative drugs.

BiopharmaBiotechnologyMedical
Series BDec 30, 2022
Amount Raised: $200,000,000
Axbio

Shenzhen, Guangdong, China

Axbio manufactures next-generation gene sequencing and diagnostic high-end equipment and providing complete industrial solutions.

ManufacturingMedical Device
Series BJun 20, 2022
Amount Raised: $100,000,000
Surgerii Technology

Haidian, Beijing, China

Surgerii Technology is a developer of minimally invasive surgical robots.

Health CareMedicalRobotics
Series CJun 1, 2022
SVOLT

Changzhou, Zhejiang, China

SVOLT is an energy tech company that specializes in the manufacturing of automotive power batteries and energy storage systems.

BatteryEnergyEnergy StorageManufacturing
Series AFeb 26, 2021
Amount Raised: $540,215,160
LianBio

Shanghai, Shanghai, China

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.

BiopharmaBiotechnologyPharmaceutical
Series AOct 29, 2020
Amount Raised: $310,000,000